Australia Slashes Rare Disease Drug Cost from $12K to $25

Lana Hallowes can finally imagine watching her sons graduate high school and maybe even meeting her grandchildren one day.

For most of her life since being diagnosed with Von Hippel Lindau disease at age 11, that future seemed impossible. She's had four brain surgeries, spinal cord surgery, and learned to walk five times.

VHL is a rare hereditary condition that causes recurring tumors to grow throughout the body. There is no cure, and patients typically live scan to scan, surgery to surgery, never knowing when the next tumor will appear.

But a breakthrough drug called Belzutifan has changed everything for Lana and hundreds of other Australians living with VHL. For the first time in her life, she doesn't need surgery.

The real game changer came when Australia listed the medication on its Pharmaceutical Benefits Scheme. Before that, treatment cost up to $12,000 every month, putting it out of reach for most families who needed it.

Now patients pay just $25 monthly for the same life-changing treatment.

"I have hope," Lana said. "I can envision my children graduating high school and maybe even having children of their own someday."

Health Minister Mark Butler called it "a demonstration of the magic of the PBS bringing the world's best medicines to Australia at affordable prices." The program ensures Australians can access cutting-edge treatments regardless of their income.

The Ripple Effect

Making this drug affordable doesn't just help individual patients. It relieves the burden on Australia's hospital system by reducing the need for repeated surgeries and emergency interventions.

Families no longer face the impossible choice between bankruptcy and treatment. Parents with VHL can now focus on raising their children instead of rationing life-saving medication.

The breakthrough also shines a light on neuroendocrine cancers, which remain widely misunderstood. Advocates say this win proves what's possible when governments prioritize access to targeted therapies, and they're calling for greater funding to develop more treatments.

For Lana, the impact is personal and profound. She's planning holidays with her boys for the first time, making memories she once thought impossible.

Hundreds of Australian families now have permission to dream about the future again.